Stem Cells and Peptides 101: Questions Everyone Actually Asks Me | #196

Two orthopedic surgeons told a 69 year old patient there was no other option left for his knees. He tried something else first, and ten years later he's still walking four miles a day.

Dr. Joy Kong is a triple board certified physician specializing in regenerative and anti-aging medicine, and the founder of Chara Health in Los Angeles. In this live audience Q&A, she explains why she uses non-expanded, umbilical cord derived mesenchymal stem cells instead of autologous or bone marrow sources, how IV delivery interacts with the immune system through the spleen, and why exosome products claiming trillions of particles per dose are not biologically realistic. She walks through real patient outcomes, including a 69 year old who avoided bilateral knee replacement, a patient whose hemoglobin A1C improved after years of failed interventions, and a peripheral neuropathy patient who regained the ability to write after three treatment sessions.

She also gets into the questions people ask most: how many sessions it actually takes to see results, what she's seen go wrong in over 40 treatments on herself, and how to spot inflated claims from clinics that don't test their products the way she does.

If you've ever wondered whether a second opinion is worth chasing down, or what actually happens inside your body after a stem cell infusion, this one covers more ground than most.

Dr. Joy talks about:

00:00 Why some patients feel change in days

05:19 The three pillars of stem cell therapy

08:31 Why the FDA restricts stem cell language

13:31 The five Ps of regenerative medicine

14:23 Why umbilical cord cells beat your own

20:54 Why expanded cells trigger FDA drug rules

22:11 How delivery route decides where cells go